According to Accelerate Diagnostics's latest financial reports the company has a price-to-book ratio of -0.6141.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | -1.63 | -48.19% |
2022-12-31 | -3.14 | -69.69% |
2021-12-31 | -10.4 | 49.15% |
2020-12-31 | -6.95 | -94.45% |
2019-12-31 | -125 | -1252.7% |
2018-12-31 | 10.9 | -11.1% |
2017-12-31 | 12.2 | -10.85% |
2016-12-31 | 13.7 | 65.85% |
2015-12-31 | 8.27 | -36.29% |
2014-12-31 | 13.0 | 6.06% |
2013-12-31 | 12.2 | 61.12% |
2012-12-31 | 7.60 | 163.35% |
2011-12-31 | 2.88 | 35.04% |
2010-12-31 | 2.14 | -13.17% |
2009-12-31 | 2.46 | -55.19% |
2008-12-31 | 5.49 | -47.54% |
2007-12-31 | 10.5 | 225.76% |
2006-12-31 | 3.21 | -5.53% |
2005-12-31 | 3.40 | 82.51% |
2004-12-31 | 1.86 | 7.67% |
2003-12-31 | 1.73 | 71.5% |
2002-12-31 | 1.01 |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | 4.72 | -868.02% | ๐บ๐ธ USA |
Becton Dickinson BDX | 2.81 | -557.83% | ๐บ๐ธ USA |
PerkinElmer
PKI | 1.80 | -393.02% | ๐บ๐ธ USA |
Bruker BRKR | 9.14 | -1,588.88% | ๐บ๐ธ USA |
NanoString Technologies NSTG | -0.1002 | -83.68% | ๐บ๐ธ USA |
Bio-Rad Laboratories BIO | 1.14 | -284.91% | ๐บ๐ธ USA |